Vivus Inc. (VVUS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

900 E. HAMILTON AVENUE CAMPBELL, CA 95008

Vivus Inc. focuses on the research, development and commercialization of products to restore sexual function in women and men. The specialty pharmaceutical company's product pipeline includes four clinical stage product candidates, each of which targets an estimated market in excess of $1 billion annually.

Data based on most recent fiscal year report
Market Cap41.321 Million Shares Outstanding105.95 Million Avg Volume1.129 Million
1-Yr BETA vs S&P TR0.582 Current Ratio6.79 Quick Ratio6.34
View SEC Filings from VVUS instead.
Q4 2018 All Institutions Hedge Funds 1
To trade VVUS now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 39 4 (0.4%)
Aggregate 13F shares on 12/31/2018: 1.746 Million 758.935 Thousand
Aggregate 13F shares on 09/30/2018: 1.809 Million 883.409 Thousand
Percent change: -3.52% -14.09%
Funds creating new positions: 5
Funds Adding to an existing position: 8 2
Funds closing out their position: 8
Funds reducing their position: 8 1
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VVUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

19.5 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ROSATI MARIO M

  • Director
59,439 2019-03-15 0

DENNER ALEXANDER J

  • Director
3,636,000 2019-03-06 0

MILLER MICHAEL PATRICK EVP, US COMMERCIAL

  • Officer
31,022 2019-03-05 0

MARIO ERNEST

60,237 2019-03-05 0

MORRIS TIMOTHY E CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-04 0

AMOS JOHN P. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,719,500 2019-03-01 9

ROBERTS ERIC W

  • Director
16,660 2019-02-28 9

FISCHER SETH H. Z.

  • Director
0 2019-02-26 0

CASAMENTO CHARLES J

  • Director
0 2019-02-20 0

SLEBIR JOHN L SVP, BUSINESS DEVELOPMENT & GC

  • Officer
0 2019-01-23 3

OKI MARK K CHIEF FINANCIAL OFFICER & CAO

  • Officer
0 2019-01-23 4

OEHRLEIN M. SCOTT CHIEF OPERATIONS OFFICER

  • Officer
0 2019-01-23 4

SUH KENNETH PRESIDENT

  • Officer
0 2019-01-23 2

VARGHESE SANTOSH T CHIEF MEDICAL OFFICER

VARGHESE SANTOSH T CHIEF MEDICAL OFFICER

  • Officer
0 2019-01-23 3

CARROLL J MARTIN

  • Director
39,925 2018-12-28 0

WILSON ROBERT N

  • Director
193,282 2018-12-13 0

VARGHESE SANTOSH T CHIEF MEDICAL OFFICER

  • Officer
7,842 2018-11-14 3

BIRO JON C CHIEF FINANCIAL OFFICER

  • Officer
6,052 2018-11-13 0

PLUTZKY JORGE MD

  • Director
8,116 2018-10-26 1

ROSENMAN HERM

  • Director
36,168 2018-10-26 5

NORTON DAVID Y

  • Director
6,712 2018-10-26 1

SHAW ALLAN

  • Director
0 2018-10-26 8

KING THOMAS BRAXTON

  • Director
0 2018-10-26 2

FERRELL KAREN E.

  • Director
0 2018-10-26 1

KANGAS EDWARD A

  • Director
0 2018-10-26 1

DENNER ALEXANDER J

SARISSA CAPITAL MANAGEMENT LP

SARISSA CAPITAL DOMESTIC FUND LP

SARISSA CAPITAL OFFSHORE MASTER FUND LP

  • 10% Owner
1,447,906 2017-08-31 0

ZOOK ANTHONY P. CEO

  • Officer
  • Director
No longer subject to file 2017-07-24 0

NORTH TIDE CAPITAL, LLC

NORTH TIDE CAPITAL MASTER, LP

LAUGHLIN CONAN

  • Director
  • 10% Owner
No longer subject to file 2017-03-08 0

SRIS MAYU

  • RESIGNED AS DIRECTOR 1/16/2017
No longer subject to file 2017-01-13 0

MOHAMED JOHANN NOOR INTERIM CFO & INTERIM CAO

  • Officer
55,244 2015-10-01 0

SANFORD SVAI S CHIEF FINANCIAL OFFICER

  • Officer
128,359 2015-08-03 0

LOGAN MARK B

  • Director
46,696 2015-07-08 0

DAY WESLEY VP, CLINICAL DEVELOPMENT

  • Officer
49,118 2015-07-01 0

MARSH GUY P VP, US OPERATIONS & GM

  • Officer
31,487 2015-01-29 0

COLIN SAMUEL F

  • Director
  • 10% Owner
3,107,979 2014-05-01 0

ASTRUE MICHAEL J INTERIM CEO

  • Officer
No longer subject to file 2014-01-10 0

JOHANNES JACOB PIETER KASTELEIN

  • Director
0 2013-08-14 0

FIRST MANHATTAN CO

FIRST BIOMED MANAGEMENT ASSOCIATES LLC

ROSENMAN HERM

BIRO JON C

NORTON DAVID Y

KEATING MELVIN L

  • 10% Owner
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
4,402,816 2013-05-23 0

BASS ROLF E.

  • 10% Owner
  • SEE REMARKS
4,402,816 2013-05-23 0

WILSON LELAND F CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
119,925 2013-01-25 0

TAM PETER Y PRESIDENT

  • Officer
  • Director
38,076 2013-01-25 0

SHORTLIFFE LINDA M DAIRIKI

  • Director
26,125 2013-01-25 0

PERRY LEE VP & CHIEF ACCOUNTING OFFICER

  • Officer
0 2013-01-25 0

MILLER MICHAEL /NY/ CHIEF COMMERCIAL OFFICER

  • Officer
5,755 2012-01-27 0

PLACE VIRGIL A CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
No longer subject to file 2010-04-30 0

STRACHAN GRAHAM

  • Director
No longer subject to file 2010-04-30 0

CHANGJIN WANG VP, BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2008-11-30 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

AMOS JOHN P. - Director - Officer CHIEF EXECUTIVE OFFICER

2019-03-01 P 11,000 $4.85 a 1,719,500 1,719,500.00 direct

ROBERTS ERIC W - Director

2019-02-28 P 8,500 $4.82 a 16,660 16,660.00 direct

AMOS JOHN P. - Director - Officer CHIEF EXECUTIVE OFFICER

2019-01-23 A 137,500 a 137,500 0.00 direct

OEHRLEIN M. SCOTT - Officer CHIEF OPERATIONS OFFICER

2019-01-23 A 31,000 a 31,000 0.00 direct

OKI MARK K - Officer CHIEF FINANCIAL OFFICER & CAO

2019-01-23 A 32,000 a 32,000 0.00 direct

VARGHESE SANTOSH T - Officer CHIEF MEDICAL OFFICER

VARGHESE SANTOSH T - Officer CHIEF MEDICAL OFFICER

2019-01-23 A 32,000 a 32,000 0.00 direct

SLEBIR JOHN L - Officer SVP, BUSINESS DEVELOPMENT & GC

2019-01-23 A 32,000 a 32,000 0.00 direct

SUH KENNETH - Officer PRESIDENT

2019-01-23 A 85,000 a 85,000 0.00 direct

VARGHESE SANTOSH T - Officer CHIEF MEDICAL OFFICER

VARGHESE SANTOSH T - Officer CHIEF MEDICAL OFFICER

2019-01-23 A 32,000 a 32,000 0.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Squarepoint Ops LLC Vivus Inc 0.62% 2018-11-07 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
Click here to report any possible errors with this stock listing.

Elevate your investments